Schierling Martina B, Doblhofer Elena, Scheibel Thomas
Lehrstuhl Biomaterialien, Universitätsstraße 30, Universität Bayreuth, Bayreuth D-95447, Germany.
Biomater Sci. 2016 Sep 20;4(10):1515-1523. doi: 10.1039/c6bm00435k.
Medical therapies are often accompanied by un-wanted side-effects or, even worse, targeted cells can develop drug resistance leading to an ineffective treatment. Therefore, drug delivery systems are under investigation to lower the risk thereof. Drug carriers should be biocompatible, biodegradable, nontoxic, non-immunogenic, and should show controllable drug loading and release properties. Previous studies qualified spider silk particles as drug delivery carriers, however, cellular uptake was only tested with unloaded spider silk particles. Here, the effect of drug loading on cellular uptake of previously established spider silk-based particles made of eADF4(C16), eADF4(C16)RGD, eADF4(C16)RG and eADF4(κ16) was investigated. Fluorescently labelled polyethylenimine was used as a model substance for loading eADF4(C16), eADF4(C16)RGD or eADF4(C16)RG particles, and fluorescently labelled ssDNA was used for loading eADF4(κ16) particles. Upon loading polyanionic eADF4(C16) and eADF4(C16)RGD particles with polycationic polyethylenimine the cellular uptake efficiency was increased, while the uptake of eADF4(C16)RG and polycationic eADF4(κ16) particles was decreased upon substance loading. The latter could be circumvented by coating substance-loaded eADF4(κ16) particles with an additional layer of eADF4(κ16) (layer-by-layer coating). Further, it could be shown that eADF4(C16)RGD and eADF4(κ16) uptake was based on clathrin-mediated endocytosis, whereas macropinocytosis was more important in case of eADF4(C16) and eADF4(C16)RG particle uptake. Finally, it was confirmed that drugs, such as doxorubicin, can be efficiently delivered into and released within cells when spider silk particles were used as a carrier.
药物治疗常常伴随着 unwanted 副作用,或者更糟糕的是,靶向细胞会产生耐药性,导致治疗无效。因此,正在研究药物递送系统以降低这种风险。药物载体应具有生物相容性、可生物降解、无毒、无免疫原性,并应表现出可控的药物负载和释放特性。先前的研究将蜘蛛丝颗粒鉴定为药物递送载体,然而,细胞摄取仅用未负载的蜘蛛丝颗粒进行了测试。在这里,研究了药物负载对先前建立的由 eADF4(C16)、eADF4(C16)RGD、eADF4(C16)RG 和 eADF4(κ16) 制成的基于蜘蛛丝的颗粒的细胞摄取的影响。荧光标记的聚乙烯亚胺用作负载 eADF4(C16)、eADF4(C16)RGD 或 eADF4(C16)RG 颗粒的模型物质,荧光标记的单链 DNA 用于负载 eADF4(κ16) 颗粒。在用聚阳离子聚乙烯亚胺负载聚阴离子 eADF4(C16) 和 eADF4(C16)RGD 颗粒后,细胞摄取效率提高,而在物质负载后,eADF4(C16)RG 和聚阳离子 eADF4(κ16) 颗粒的摄取减少。后者可以通过用额外的一层 eADF4(κ16)(逐层包被)包被负载物质的 eADF4(κ16) 颗粒来规避。此外,可以证明 eADF4(C16)RGD 和 eADF4(κ16) 的摄取基于网格蛋白介导的内吞作用,而巨胞饮作用在 eADF4(C16) 和 eADF4(C16)RG 颗粒摄取的情况下更为重要。最后,证实了当使用蜘蛛丝颗粒作为载体时,阿霉素等药物可以有效地递送到细胞内并在细胞内释放。